Nora D. Volkow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nora D. Volkow has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Joanna S. Fowler
24 shared publicationsGene-Jack Wang
19 shared publicationsRobert Hitzemann
15 shared publicationsYu-Shin Ding
15 shared publicationsJean Logan
13 shared publicationsNaomi Pappas
13 shared publications
Latest Publications
- 1 March 2005
- Published by Elsevier in Biological Psychiatry
- Vol. 57 (6) , 640-646
The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects
- 1 March 2005
- Published by Elsevier in Biological Psychiatry
- Vol. 57 (6) , 640-646
The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects
- 17 July 2003
- Published by Elsevier in Life Sciences
- Vol. 73 (15) , 1953-1961
Abnormal brain activation to visual stimulation in cocaine abusers
- 17 July 2003
- Published by Elsevier in Life Sciences
- Vol. 73 (15) , 1953-1961
Abnormal brain activation to visual stimulation in cocaine abusers
- 15 May 2003
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 111 (10) , 1444-1451
The addicted human brain: insights from imaging studies
- 15 May 2003
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 111 (10) , 1444-1451
The addicted human brain: insights from imaging studies
- 25 February 2003
- Published by Wiley in International Journal of Eating Disorders
- Vol. 33 (2) , 136-142
Brain dopamine is associated with eating behaviors in humans
Objective: Eating behavior in humans is influenced by variables other than just hunger‐satiety including cognitive restraint, emotional distress, and sensitivity to food stimuli. We investigate the role of dopamine (DA), a neurotransmitter involved with food motivation, in these variables.Methods: We used the Dutch Eating Behavior Questionnaire (DEBQ) to measure Restraint, Emotionality, and Externality in 10 subjects. We correlated DEBQ scores with brain DA levels. Positron emission tomography and {11C}raclopride uptake were used to measure baseline D2 receptors (neutral stimulation) and to assess changes in extracellular DA to food stimulation (display of food).Results: Restraint was correlated with DA changes with food stimulation (higher restraint, greater responsivity), emotionality was negatively correlated with baseline D2 receptors (higher emotionality, lower D2 receptors), whereas externality was not. These correlations were significant in the dorsal but not in the ventral striatum.Discussion: These results provide evidence that DA in the dorsal striatum is involved with the restraint and emotionality components regulating eating behavior and that these two dimensions reflect different neurobiologic processes. © 2003 by Wiley Periodicals, Inc.Int J Eat Disord 33: 136–142, 2003.
- 25 February 2003
- Published by Wiley in International Journal of Eating Disorders
- Vol. 33 (2) , 136-142
Brain dopamine is associated with eating behaviors in humans
Objective: Eating behavior in humans is influenced by variables other than just hunger‐satiety including cognitive restraint, emotional distress, and sensitivity to food stimuli. We investigate the role of dopamine (DA), a neurotransmitter involved with food motivation, in these variables.Methods: We used the Dutch Eating Behavior Questionnaire (DEBQ) to measure Restraint, Emotionality, and Externality in 10 subjects. We correlated DEBQ scores with brain DA levels. Positron emission tomography and {11C}raclopride uptake were used to measure baseline D2 receptors (neutral stimulation) and to assess changes in extracellular DA to food stimulation (display of food).Results: Restraint was correlated with DA changes with food stimulation (higher restraint, greater responsivity), emotionality was negatively correlated with baseline D2 receptors (higher emotionality, lower D2 receptors), whereas externality was not. These correlations were significant in the dorsal but not in the ventral striatum.Discussion: These results provide evidence that DA in the dorsal striatum is involved with the restraint and emotionality components regulating eating behavior and that these two dimensions reflect different neurobiologic processes. © 2003 by Wiley Periodicals, Inc.Int J Eat Disord 33: 136–142, 2003.
- 13 February 2003
- Published by Springer Nature in Psychopharmacology
- Vol. 166 (3) , 264-270
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma
The cardiovascular effects of psychostimulant drugs (methylphenidate, amphetamine, cocaine) have been mostly associated with their noradrenergic effects. However, there is some evidence that dopaminergic effects are involved in the cardiovascular actions of these drugs. Here, we evaluated this association in humans.
- 13 February 2003
- Published by Springer Nature in Psychopharmacology
- Vol. 166 (3) , 264-270
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma
The cardiovascular effects of psychostimulant drugs (methylphenidate, amphetamine, cocaine) have been mostly associated with their noradrenergic effects. However, there is some evidence that dopaminergic effects are involved in the cardiovascular actions of these drugs. Here, we evaluated this association in humans.
- 1 December 2002
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 116 (3) , 163-172
Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study
- 1 December 2002
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 116 (3) , 163-172
Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study
- 1 December 2002
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 12 (6) , 557-566
Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies
- 1 December 2002
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 12 (6) , 557-566
Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies
- 1 November 2002
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 78 (3) , 610-624
Role of Dopamine, the Frontal Cortex and Memory Circuits in Drug Addiction: Insight from Imaging Studies
- 1 November 2002
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 78 (3) , 610-624
Role of Dopamine, the Frontal Cortex and Memory Circuits in Drug Addiction: Insight from Imaging Studies
- 1 September 2002
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 13 (5) , 355-366
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies
The involvement of dopamine (DA) in drug reinforcement is well established, but much less in known about its contribution to addiction. We have used positron emission tomography to investigate in humans the role of DA in drug reinforcement, addiction and drug vulnerability. We have shown that during drug intoxication increases in striatal DA are associated with the drug's reinforcing effects only if the DA changes occur rapidly. These results corroborate the relevance of drug-induced DA increases and of pharmacokinetics in the rewarding effects of drugs in humans. During withdrawal, we have shown significant reductions in DA D2 receptors and in DA release in drug abusers, which is likely to result in decreased sensitivity to non-drug-related reinforcing stimuli. The DA D2 reductions were associated with decreased activity in the orbitofrontal cortex, which we postulate is one of the mechanisms underlying compulsive drug administration in the addict. In fact, during craving the orbitofrontal cortex becomes hyperactive in proportion to the desire for the drug. In non-drug-abusing subjects striatal DA D2 receptors levels predicted the reinforcing responses to stimulant drugs, providing evidence that striatal DA D2 receptors modulate reinforcing responses to stimulants in humans and may contribute to the predisposition for drug self-administration
- 1 September 2002
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 13 (5) , 355-366
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies
The involvement of dopamine (DA) in drug reinforcement is well established, but much less in known about its contribution to addiction. We have used positron emission tomography to investigate in humans the role of DA in drug reinforcement, addiction and drug vulnerability. We have shown that during drug intoxication increases in striatal DA are associated with the drug's reinforcing effects only if the DA changes occur rapidly. These results corroborate the relevance of drug-induced DA increases and of pharmacokinetics in the rewarding effects of drugs in humans. During withdrawal, we have shown significant reductions in DA D2 receptors and in DA release in drug abusers, which is likely to result in decreased sensitivity to non-drug-related reinforcing stimuli. The DA D2 reductions were associated with decreased activity in the orbitofrontal cortex, which we postulate is one of the mechanisms underlying compulsive drug administration in the addict. In fact, during craving the orbitofrontal cortex becomes hyperactive in proportion to the desire for the drug. In non-drug-abusing subjects striatal DA D2 receptors levels predicted the reinforcing responses to stimulant drugs, providing evidence that striatal DA D2 receptors modulate reinforcing responses to stimulants in humans and may contribute to the predisposition for drug self-administration
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study
We had shown that striatal DA D2 receptors levels predicted the reinforcing responses to the psychostimulant drug methylphenidate in nondrug‐abusing subjects. Here, we assessed the replicability of this finding. We measured D2 receptors with PET and [11C]raclopride (twice to determine stability) in seven nondrug‐abusing subjects to assess if they predicted the self‐reports of “drug‐liking” to intravenous methylphenidate (0.5 mg/kg). DA D2 measures were significantly correlated with “drug‐liking” in both evaluations (r = 0.82 and r = 0.78); subjects with the lowest levels reported the higher ratings of “drug‐liking” and vice versa. These results replicate our previous findings and provide further evidence that striatal DA D2 receptors modulate reinforcing responses to stimulants in humans and may underlie predisposition for drug self‐administration. Synapse 46:79–82, 2002.
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study
We had shown that striatal DA D2 receptors levels predicted the reinforcing responses to the psychostimulant drug methylphenidate in nondrug‐abusing subjects. Here, we assessed the replicability of this finding. We measured D2 receptors with PET and [11C]raclopride (twice to determine stability) in seven nondrug‐abusing subjects to assess if they predicted the self‐reports of “drug‐liking” to intravenous methylphenidate (0.5 mg/kg). DA D2 measures were significantly correlated with “drug‐liking” in both evaluations (r = 0.82 and r = 0.78); subjects with the lowest levels reported the higher ratings of “drug‐liking” and vice versa. These results replicate our previous findings and provide further evidence that striatal DA D2 receptors modulate reinforcing responses to stimulants in humans and may underlie predisposition for drug self‐administration. Synapse 46:79–82, 2002.